Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blocking HIV co-receptors by chemokines.

J L Virelizier1

  • 1Unité d'Immunologie Virale, Institut Pasteur, Paris, France.

Developments in Biological Standardization
|August 27, 1999
PubMed
Summary

Specific chemokines block HIV entry by targeting viral co-receptors like CCR5 and CXCR4. Understanding HIV tropism is crucial for developing effective antiviral therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunological assays and correlates of immunity.

Developments in biologicals·2004
Same author

Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor.

The Journal of biological chemistry·2001
Same author

Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes.

Journal of virology·2001
Same author

Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans.

The Journal of biological chemistry·2001
Same author

Inducible NF-kappaB activation is permitted by simultaneous degradation of nuclear IkappaBalpha.

The Journal of biological chemistry·2000
Same author

Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin.

The American journal of pathology·1999

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Chemokines can inhibit human immunodeficiency virus (HIV) entry and replication by blocking its use of chemokine receptors on CD4+ cells.
  • This antiviral mechanism has generated significant academic and therapeutic interest due to its potential in HIV treatment.

Discussion:

  • The effectiveness of chemokines varies depending on the specific chemokine and the HIV isolate, as HIV utilizes multiple co-receptors.
  • Known co-receptors include CCR5, CCR3, CXCR4, STRL33/Bonzo/TYMSTR, and BOB.
  • CC chemokines like RANTES, MIP-1alpha, MIP-1beta, and Eotaxin inhibit CCR5- and CCR3-dependent viruses, while SDF-1 alpha/beta targets CXCR4-dependent strains.

Key Insights:

  • Chronic HIV infection can lead to viral strains that use multiple co-receptors, not just CCR5.
  • This necessitates the assessment of primary HIV isolates' tropism.

Outlook:

  • Assaying HIV tropism using fusion assays and chemokine protection of lymphocyte cultures is vital.
  • Further research into chemokine-based therapies and co-receptor interactions is warranted.

Related Experiment Videos